surpass-2 tirzepatide vs semaglutide weight loss and key differences, results (2026) Semaglutide vs Tirzepatide: Effectiveness, Side

Wegovy: Subcutaneous injection approved by the FDA on June 4, 2021, for chronic weight management in patients with obesity (body mass index of 30 or more) and overweight (body mass index of 27 or more) with a weight-related condition like cardiovascular disease, high blood pressure, or type 2 diabetes

Am J Clin Nutr 1998;67:1250-5

Vancomycin-induced acute generalized exanthematous pustulosis (AGEP) masquerading septic shock an unusual presentation of a rare disease

Hormone delivery method optimization Before starting a GLP-1 medication, evaluate your HRT delivery method: If you are on oral HRT: Talk to your provider about switching to transdermal delivery (patches or gels) for estrogen, and either a Mirena IUD or transvaginal delivery for progesterone

Compounded tirzepatide is not FDA-approved as a finished drug product